Showing results (1-10 of 2,114) with videos related to
Sort By:
Pageof 212
Radioisotopes|August 1, 1990
Evaluation of 3H-paroxetine as a radioligand for in vivo study of 5-hydroxytryptamine uptake sites in mouse brainK Hashimoto, T GoromaruNeuropharmacology|July 1, 1990
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamineK Hashimoto, T GoromaruRadioisotopes|April 1, 1990
Preparation of [3H]6-nitroquipazine, a potent and selective 5-hydroxytryptamine uptake inhibitorK Hashimoto, T GoromaruFundamental & Clinical Pharmacology|January 1, 1990
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamineK Hashimoto, T GoromaruEuropean Journal of Pharmacology|May 16, 1990
High-affinity [3H]6-nitroquipazine binding sites in rat brainK Hashimoto, T GoromaruThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazineK Hashimoto, T GoromaruKaku Igaku. the Japanese Journal of Nuclear Medicine|July 1, 1989
[Evaluation of 3H-paroxetine as a radiopharmaceutical for lung function]K Hashimoto, T GoromaruBiochemical Pharmacology|June 1, 1991
High-affinity [3H]6-nitroquipazine binding to the 5-hydroxytryptamine transport system in rat lungK Hashimoto, T GoromaruNeuropharmacology|February 1, 1991
High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitorsK Hashimoto, T GoromaruEuropean Journal of Pharmacology|October 23, 1990
High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human plateletsK Hashimoto, T GoromaruPageof 212